The pathogenesis of glomerular sclerosis observed in FSGS patients may be caused by an increase in glomerular profibrotic cytokines, such as IL-13, IL-4, or TGF-β [70–73]. The gene discussed is TGFB1; the disease is focal segmental glomerulosclerosis.